Program

2024

• Clinical and molecular pathology

• Digital pathology and artificial inteligence (AI)

• Interdisciplinary research in pathology

• Biomarkers in personalized medicine

• Molecular targets and novel cancer drugs

• Early cancer detection and prevention

• Multidisciplinary cancer research

• Translational research in oncology

• Data management and AI in cancer research

Keynote talks

Jonathan S. Duke-Cohan

T cell immunotherapies: Some molecular insights from the basic science perspective

Department of Medical Oncology, Dana
Farber Cancer Institute,Boston MA , USA

Viktor Umansky

Immunosuppression in tumor microenvironment mediated by myeloid-derived suppressor cells (MDSC)

German Cancer Research Center (DKFZ), Heidelberg, Germany
Ruprecht-Karl University of Heidelberg, Heidelberg, Germany

Jindřich Kopeček

Drug-Free Macromolecular Therapeutics

Center for Controlled Chemical Delivery, University of Utah, Salt Lake City, Utah, USA
Departments of Molecular Pharmaceutics and of Biomedical Engineering, Salt Lake City, Utah, USA

Oral presentation

Unless otherwise specified (e.g. for invited speakers) regular presentation is scheduled to 10-12 minutes of talk plus 3 minutes for discussion. Speakers are recommended to prepare slides in MS PowerPoint software.

Invited speaker presentation is scheduled to 30 minutes.

Poster presentation

Poster size: A0 841 mm (width) x 1189 (height)

Professional guarantee

Organizers